Lipoprotein disorders causes: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(20 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Hyperlipidemia}}
{{Hyperlipidemia}}
{{CMG}}; {{AE}} {{HP}}; {{Hilda}}
{{CMG}}; {{AE}} {{HP}}; {{Hilda}}
{{PleaseHelp}}


==Overview==
==Overview==
Line 9: Line 11:
===Common Causes===
===Common Causes===
*[[Alcohol abuse]]
*[[Alcohol abuse]]
*[[Chronic renal failure]]
*[[Chronic renal failure]]
*[[Combined oral contraceptive pill]]
*[[Combined oral contraceptive pill]]
*[[Diabetes mellitus type 2]]
*[[Diabetes mellitus type 2]]
 
*[[Fat|High fat diet]]
*High fat diet
 
*[[Hypothyroidism]]
*[[Hypothyroidism]]
*[[Intrahepatic cholestasis]]
*[[Intrahepatic cholestasis]]
*[[Nephrotic syndrome]]
*[[Nephrotic syndrome]]
*[[Obesity]]
*[[Obesity]]
*[[Pregnancy]]
*[[Pregnancy]]
Line 42: Line 36:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical antipsychotics]], [[bendrofluazide]], [[beta blockers]], [[bexarotene]], [[chenodeoxycholic acid]], [[chlorthalidone]], [[clofibrate]], [[clozapine]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive pill]], [[cyclopenthiazide]], [[danazol]], [[desvenlafaxine]], [[doxazosin]], [[etretinate]], [[fosamprenavir]], [[gestrinone]], [[hydrochlorothiazide]], [[interferon alpha]], [[isotretinoin]], [[linagliptin]], [[lopinavir]], [[mitotane]], [[nelfinavir]], [[olanzapine]], [[prazosin]], [[progestagens]], [[propofol]], [[protease inhibitors]], [[ritonavir]], [[rosiglitazone]], [[saquinavir]], [[sirolimus]], [[temsirolimus]], [[testosterone]], [[thiazide diuretics]], [[tipranavir]], [[tocilizumab]], tofacitinib, [[torcetrapib]]
|bgcolor="Beige"| [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical antipsychotics]], [[bendrofluazide]], [[beta blockers]], [[bexarotene]], [[chenodeoxycholic acid]], [[chlorthalidone]], [[clofibrate]], [[clozapine]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive pill]], [[cyclopenthiazide]], [[danazol]], [[desvenlafaxine]], [[doxazosin]], [[etretinate]], [[everolimus]], [[febuxostat]], [[fosamprenavir]], [[gestrinone]], [[hydrochlorothiazide]], [[Iloperidone]],  [[interferon alpha]], [[isotretinoin]], [[linagliptin]], [[lopinavir]], [[mitotane]], [[nelfinavir]], [[olanzapine]], [[Pegaspargase]], [[pramipexole]], [[prazosin]], [[progestagens]], [[propofol]], [[protease inhibitors]], [[ritonavir]], [[rosiglitazone]], [[saquinavir]], [[sirolimus]], [[temsirolimus]], [[testosterone]], [[thiazide diuretics]], [[tipranavir]], [[tocilizumab]], [[tofacitinib]], [[torcetrapib]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 58: Line 52:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
| '''Gastroenterologic'''
|bgcolor="Beige"| [[Cholestatic jaundice]], [[intrahepatic cholestasis]], malignant hepatopathy, [[pancreatitis]], [[Alagille syndrome]]
|bgcolor="Beige"| [[Cholestatic jaundice]], [[intrahepatic cholestasis]], [[pancreatitis]], [[Alagille syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Genetic'''
| '''Genetic'''
|bgcolor="Beige"| [[Alagille syndrome]], [[Alstrom syndrome]], [[analbuminaemia]], apolipoprotein C-II deficiency, apoprotein E deficiency, Berardinelli-Seip congenital lipodystrophy, [[carnitine palmitoyltransferase 1 deficiency]], chromosome 15q deletion, [[familial alphalipoprotein deficiency]], familial defective apolipoprotein B-100, [[familial hypertriglyceridaemia]], familial isolated vitamin E deficiency, [[familial mixed hyperlipidemia]], [[fructose-1, 6-diphosphatase deficiency]], [[glycogen storage diseases]], [[lecithin cholesterol acyltransferase deficiency]], [[lipoprotein lipase deficiency]], [[Niemann-Pick disease]], primary hyperlipoproteinemia, [[Smith-Lemli-Opitz syndrome]], [[Werner syndrome]]
|bgcolor="Beige"| [[Alagille syndrome]], [[Alstrom syndrome]], [[analbuminaemia]], [[apolipoprotein C2|apolipoprotein C-II deficiency]], [[apolipoprotein E|apoliprotein E deficiency]], [[Berardinelli lipodystrophy syndrome|Berardinelli-Seip congenital lipodystrophy]], [[carnitine palmitoyltransferase 1 deficiency]], [[Chromosome 15q partial deletion|chromosome 15q deletion]], [[chylomicronemia]], [[familial alphalipoprotein deficiency]], [[Apolipoprotein B deficiency|familial defective apolipoprotein B-100]], [[familial hypertriglyceridaemia]], [[familial isolated vitamin E deficiency]], [[familial mixed hyperlipidemia]], [[fructose-1, 6-diphosphatase deficiency]], [[glycogen storage diseases]], [[lecithin cholesterol acyltransferase deficiency]], [[lipoprotein lipase deficiency]], [[Niemann-Pick disease]], [[hyperlipoproteinemia|primary hyperlipoproteinemia]], [[Smith-Lemli-Opitz syndrome]], [[Werner syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 86: Line 80:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Nutritional / Metabolic'''
| '''Nutritional / Metabolic'''
|bgcolor="Beige"| Dysglobulinemia, [[LDL receptor deficiency]], omega-3 polyunsaturated fatty acids, [[selenium deficiency]], [[vitamin E deficiency]], [[Smith-Lemli-Opitz syndrome]], apolipoprotein C-II deficiency, apoprotein E deficiency, [[carnitine palmitoyltransferase 1 deficiency]], familial isolated vitamin E deficiency, [[fructose-1, 6-diphosphatase deficiency]], [[glycogen storage diseases]], [[lecithin cholesterol acyltransferase deficiency]], [[lipoprotein lipase deficiency]], [[Niemann-Pick disease]], primary hyperlipoproteinemia
|bgcolor="Beige"| Dysglobulinemia, [[LDL receptor deficiency]], [[Polyunsaturated fat|omega-3 polyunsaturated fatty acids]], [[selenium deficiency]], [[vitamin E deficiency]], [[Smith-Lemli-Opitz syndrome]], [[apolipoprotein C2|apolipoprotein C-II deficiency, apoprotein E deficiency]], [[carnitine palmitoyltransferase 1 deficiency]], [[familial isolated vitamin E deficiency]], [[fructose-1, 6-diphosphatase deficiency]], [[glycogen storage diseases]], [[lecithin cholesterol acyltransferase deficiency]], [[lipoprotein lipase deficiency]], [[Niemann-Pick disease]], [[hyperlipoproteinemia|primary hyperlipoproteinemia]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 102: Line 96:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Overdose / Toxicity'''
| '''Overdose / Toxicity'''
|bgcolor="Beige"| [[Amprenavir]], atazanavir sulfate, [[atypical antipsychotics]], [[bendrofluazide]], [[beta blockers]], [[bexarotene]], [[chenodeoxycholic acid]], [[chlorthalidone]], [[clofibrate]], colesevelam hydrochloride, [[colestyramine]], [[combined oral contraceptive pill]], [[cyclopenthiazide]], [[danazol]], [[desvenlafaxine]], [[doxazosin]], [[etretinate]], [[fosamprenavir]], [[gestrinone]], [[hydrochlorothiazide]], [[interferon alpha]], [[isotretinoin]], [[linagliptin]], [[lopinavir]], [[mitotane]], [[nelfinavir]], [[prazosin]], [[progestagens]], [[propofol]], [[protease inhibitors]], [[ritonavir]], [[rosiglitazone]], [[saquinavir]], [[sirolimus]], [[temsirolimus]], [[testosterone]], [[thiazide diuretics]], [[tipranavir]], [[tocilizumab]], tofacitinib, [[torcetrapib]]
|bgcolor="Beige"| [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical antipsychotics]], [[bendrofluazide]], [[beta blockers]], [[bexarotene]], [[chenodeoxycholic acid]], [[chlorthalidone]], [[clofibrate]], [[clozapine]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive pill]], [[cyclopenthiazide]], [[danazol]], [[desvenlafaxine]], [[doxazosin]], [[etretinate]], [[fosamprenavir]], [[gestrinone]], [[hydrochlorothiazide]], [[interferon alpha]], [[isotretinoin]], [[linagliptin]], [[lopinavir]], [[mitotane]], [[nelfinavir]], [[olanzapine]] [[prazosin]], [[progestagens]], [[propofol]], [[protease inhibitors]], [[ritonavir]], [[rosiglitazone]], [[saquinavir]], [[sirolimus]], [[temsirolimus]], [[testosterone]], [[thiazide diuretics]], [[tipranavir]], [[tocilizumab]], [[tofacitinib]], [[torcetrapib]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 138: Line 132:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Miscellaneous'''
| '''Miscellaneous'''
|bgcolor="Beige"| [[Alcohol abuse]], benign symmetrical lipomatosis, [[exercise]], high fat diet, [[obesity]], positive family history, [[sedentary lifestyle]], [[stress]], [[tobacco smoking]]
|bgcolor="Beige"| [[Alcohol abuse]], [[lipomatosis|benign symmetrical lipomatosis]], [[exercise]], [[fat|high fat diet]], [[obesity]], [[family history|positive family history]], [[sedentary lifestyle]], [[stress]], [[tobacco smoking]]
|-
|-
|}
|}
Line 151: Line 145:
*[[Analbuminaemia]]
*[[Analbuminaemia]]
*[[Anorexia nervosa]]
*[[Anorexia nervosa]]
*Apolipoprotein C-II deficiency<ref>[http://omim.org/entry/207750 OMIM entry 207750] last updated 02/10/2009</ref><ref>{{cite pmid|227429}}</ref><ref name="Andrews">{{cite book |author=James, William D.; Berger, Timothy G.; et al. |title=Andrews' Diseases of the Skin: clinical Dermatology |publisher=Saunders Elsevier |location= |year=2006 |pages= |isbn=0-7216-2921-0 |oclc= |doi= |accessdate=}}</ref>
*[[apolipoprotein C2|Apolipoprotein C-II deficiency]]<ref>[http://omim.org/entry/207750 OMIM entry 207750] last updated 02/10/2009</ref><ref>{{cite pmid|227429}}</ref><ref name="Andrews">{{cite book |author=James, William D.; Berger, Timothy G.; et al. |title=Andrews' Diseases of the Skin: clinical Dermatology |publisher=Saunders Elsevier |location= |year=2006 |pages= |isbn=0-7216-2921-0 |oclc= |doi= |accessdate=}}</ref>
*Apoprotein E deficiency
*[[Apolipoprotein E|Apoprotein E deficiency]]
*Atazanavir sulfate
*[[Atazanavir|Atazanavir sulfate]]
*[[Atypical antipsychotics]]<ref name="pmid11603884">{{cite journal| author=Henderson DC| title=Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. | journal=J Clin Psychiatry | year= 2001 | volume= 62 Suppl 23 | issue=  | pages= 39-44 | pmid=11603884 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11603884  }} </ref>  
*[[Atypical antipsychotics]]<ref name="pmid11603884">{{cite journal| author=Henderson DC| title=Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. | journal=J Clin Psychiatry | year= 2001 | volume= 62 Suppl 23 | issue=  | pages= 39-44 | pmid=11603884 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11603884  }} </ref>  
*[[Bendrofluazide]]
*[[Bendrofluazide]]
*Benign symmetrical lipomatosis
*[[Lipomatosis|Benign symmetrical lipomatosis]]
*Berardinelli-Seip congenital lipodystrophy
*[[Berardinelli lipodystrophy syndrome|Berardinelli-Seip congenital lipodystrophy]]
*[[Beta blockers]]
*[[Beta blockers]]
*[[Bexarotene]]
*[[Bexarotene]]
Line 164: Line 158:
*[[Chlorthalidone]]
*[[Chlorthalidone]]
*[[Cholestatic jaundice]]<ref name="pmid2323525">{{cite journal| author=Rosenson RS, Baker AL, Chow MJ, Hay RV| title=Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. | journal=Gastroenterology | year= 1990 | volume= 98 | issue= 5 Pt 1 | pages= 1351-7 | pmid=2323525 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2323525  }} </ref>
*[[Cholestatic jaundice]]<ref name="pmid2323525">{{cite journal| author=Rosenson RS, Baker AL, Chow MJ, Hay RV| title=Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. | journal=Gastroenterology | year= 1990 | volume= 98 | issue= 5 Pt 1 | pages= 1351-7 | pmid=2323525 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2323525  }} </ref>
*Chromosome 15q deletion
*[[Chromosome 15q partial deletion|Chromosome 15q deletion]]
*[[Chronic renal failure]]
*[[Chronic renal failure]]
*[[Chylomicronemia]]<ref>[http://omim.org/entry/118830 OMIM entry 118830] updated 03/18/2004</ref>
*[[Chylomicronemia]]<ref>[http://omim.org/entry/118830 OMIM entry 118830] updated 03/18/2004</ref>
*[[Clofibrate]]
*[[Clofibrate]]
*[[Clozapine]]<ref name="pmid11603884">{{cite journal| author=Henderson DC| title=Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. | journal=J Clin Psychiatry | year= 2001 | volume= 62 Suppl 23 | issue=  | pages= 39-44 | pmid=11603884 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11603884  }} </ref>  
*[[Clozapine]]<ref name="pmid11603884">{{cite journal| author=Henderson DC| title=Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. | journal=J Clin Psychiatry | year= 2001 | volume= 62 Suppl 23 | issue=  | pages= 39-44 | pmid=11603884 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11603884  }} </ref>  
*Colesevelam hydrochloride
*[[Colesevelam|Colesevelam hydrochloride]]
*[[Colestyramine]]
*[[Colestyramine]]
*[[Combined oral contraceptive pill]]
*[[Combined oral contraceptive pill]]
Line 177: Line 171:
*[[Desvenlafaxine]]
*[[Desvenlafaxine]]
*[[Diabetes mellitus type 2]]<ref name="pmid3893447">{{cite journal| author=Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A et al.| title=Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. | journal=Atherosclerosis | year= 1985 | volume= 55 | issue= 3 | pages= 259-66 | pmid=3893447 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3893447  }} </ref>
*[[Diabetes mellitus type 2]]<ref name="pmid3893447">{{cite journal| author=Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A et al.| title=Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. | journal=Atherosclerosis | year= 1985 | volume= 55 | issue= 3 | pages= 259-66 | pmid=3893447 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3893447  }} </ref>
{{col-break|width=33%}}
*[[Doxazosin]]
*[[Doxazosin]]
{{col-break|width=33%}}
*Dysglobulinemia
*Dysglobulinemia
*[[Etretinate]]
*[[Etretinate]]
*[[Exercise]]
*[[Exercise]]
*[[Familial alphalipoprotein deficiency]]
*[[Familial alphalipoprotein deficiency]]
*Familial defective apolipoprotein B-100
*[[Apolipoprotein B deficiency|Familial defective apolipoprotein B-100]]
*[[Familial hypertriglyceridaemia]]
*[[Familial hypertriglyceridaemia]]
*Familial isolated vitamin E deficiency
*[[Familial isolated vitamin E deficiency]]
*[[Familial mixed hyperlipidemia]]
*[[Familial mixed hyperlipidemia]]
*[[Fosamprenavir]]
*[[Fosamprenavir]]
Line 192: Line 186:
*[[Glycogen storage diseases]]
*[[Glycogen storage diseases]]
*[[Growth hormone secreting pituitary adenoma]]
*[[Growth hormone secreting pituitary adenoma]]
*High fat diet
*[[Fat|High fat diet]]
*[[Hydrochlorothiazide]]
*[[Hydrochlorothiazide]]
*[[Hypopituitarism]]
*[[Hypopituitarism]]
Line 205: Line 199:
*[[Lopinavir]]
*[[Lopinavir]]
*[[Macrophage activation syndrome]]
*[[Macrophage activation syndrome]]
*Malignant hepatopathy
*[[Metabolic syndrome]]
*[[Metabolic syndrome]]
*[[Mitotane]]
*[[Mitotane]]
*[[Nelfinavir]]
*[[Nelfinavir]]
*[[Nephrotic syndrome]]
*[[Nephrotic syndrome]]
{{col-break|width=33%}}
*[[Niemann-Pick disease ]]
*[[Niemann-Pick disease ]]
*[[Obesity]]<ref name="pmid6219830">{{cite journal| author=Hubert HB, Feinleib M, McNamara PM, Castelli WP| title=Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. | journal=Circulation | year= 1983 | volume= 67 | issue= 5 | pages= 968-77 | pmid=6219830 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6219830  }} </ref>
*[[Obesity]]<ref name="pmid6219830">{{cite journal| author=Hubert HB, Feinleib M, McNamara PM, Castelli WP| title=Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. | journal=Circulation | year= 1983 | volume= 67 | issue= 5 | pages= 968-77 | pmid=6219830 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6219830  }} </ref>
{{col-break|width=33%}}
*[[olanzapine]]<ref name="pmid10584766">{{cite journal| author=Osser DN, Najarian DM, Dufresne RL| title=Olanzapine increases weight and serum triglyceride levels. | journal=J Clin Psychiatry | year= 1999 | volume= 60 | issue= 11 | pages= 767-70 | pmid=10584766 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10584766  }} </ref>
*[[olanzapine]]<ref name="pmid10584766">{{cite journal| author=Osser DN, Najarian DM, Dufresne RL| title=Olanzapine increases weight and serum triglyceride levels. | journal=J Clin Psychiatry | year= 1999 | volume= 60 | issue= 11 | pages= 767-70 | pmid=10584766 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10584766  }} </ref>
*Omega-3 polyunsaturated fatty acids
*[[ Polyunsaturated fat|Omega-3 polyunsaturated fatty acids]]
*[[Pancreatitis]]
*[[Pancreatitis]]
*[[Parenteral nutrition]]
*[[Parenteral nutrition]]
*Positive family history
*[[Pegaspargase]]
*[[Family History|Positive family history]]
*[[Prazosin]]
*[[Prazosin]]
*[[Pregnancy]]
*[[Pregnancy]]
*Primary hyperlipoproteinemia
*[[Hyperlipoproteinemia|Primary hyperlipoproteinemia]]
*[[Progestagens]]
*[[Progestagens]]
*[[Propofol]]
*[[Propofol]]
Line 239: Line 233:
*[[Tobacco smoking]]<ref name="pmid1349365">{{cite journal| author=Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM| title=Insulin resistance and cigarette smoking. | journal=Lancet | year= 1992 | volume= 339 | issue= 8802 | pages= 1128-30 | pmid=1349365 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1349365  }} </ref>
*[[Tobacco smoking]]<ref name="pmid1349365">{{cite journal| author=Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM| title=Insulin resistance and cigarette smoking. | journal=Lancet | year= 1992 | volume= 339 | issue= 8802 | pages= 1128-30 | pmid=1349365 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1349365  }} </ref>
*[[Tocilizumab]]
*[[Tocilizumab]]
*Tofacitinib
*[[Tofacitinib]]
*[[Torcetrapib]]
*[[Torcetrapib]]
*[[Vitamin E deficiency]]
*[[Vitamin E deficiency]]
Line 248: Line 242:
{{reflist|2}}
{{reflist|2}}


{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Lipid disorders]]
[[Category:Endocrinology]]
[[Category:Mature chapter]]
 
[[Category:Genetic disorders]]
{{WS}}
[[Category:Metabolic disorders]]
{{WH}}

Latest revision as of 18:27, 21 July 2016

Lipoprotein Disorders Microchapters

Patient Information

Overview

Causes

Classification

Hyperlipoproteinemia
Hypolipoproteinemia

Treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hardik Patel, M.D.; Hilda Mahmoudi M.D., M.P.H.[2]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Lipid and lipoprotein abnormalities are common in the general population and are regarded as a modifiable risk factor for cardiovascular diseases due to their contribution to atherosclerosis. The causes of hyperlipidemia can be primary or secondary. Primary hyperlipidemia is usually due to genetic etiologies, such as mutations in receptor proteins, which include chylomicronemia, hypercholesterolemia, dysbetalipoproteinemia, hypertriglyceridemia, mixed hyperlipoproteinemia and combined hyperlipoproteinemia. Secondary hyperlipidemia results from other underlying conditions such as diabetes.

Causes

Common Causes

Causes by Organ System

Cardiovascular Alagille syndrome
Chemical / poisoning No underlying causes
Dermatologic No underlying causes
Drug Side Effect Amprenavir, atazanavir sulfate, atypical antipsychotics, bendrofluazide, beta blockers, bexarotene, chenodeoxycholic acid, chlorthalidone, clofibrate, clozapine, colesevelam hydrochloride, colestyramine, combined oral contraceptive pill, cyclopenthiazide, danazol, desvenlafaxine, doxazosin, etretinate, everolimus, febuxostat, fosamprenavir, gestrinone, hydrochlorothiazide, Iloperidone, interferon alpha, isotretinoin, linagliptin, lopinavir, mitotane, nelfinavir, olanzapine, Pegaspargase, pramipexole, prazosin, progestagens, propofol, protease inhibitors, ritonavir, rosiglitazone, saquinavir, sirolimus, temsirolimus, testosterone, thiazide diuretics, tipranavir, tocilizumab, tofacitinib, torcetrapib
Ear Nose Throat No underlying causes
Endocrine Cushing syndrome, diabetes mellitus type 2, hypothyroidism, metabolic syndrome, hypopituitarism
Environmental No underlying causes
Gastroenterologic Cholestatic jaundice, intrahepatic cholestasis, pancreatitis, Alagille syndrome
Genetic Alagille syndrome, Alstrom syndrome, analbuminaemia, apolipoprotein C-II deficiency, apoliprotein E deficiency, Berardinelli-Seip congenital lipodystrophy, carnitine palmitoyltransferase 1 deficiency, chromosome 15q deletion, chylomicronemia, familial alphalipoprotein deficiency, familial defective apolipoprotein B-100, familial hypertriglyceridaemia, familial isolated vitamin E deficiency, familial mixed hyperlipidemia, fructose-1, 6-diphosphatase deficiency, glycogen storage diseases, lecithin cholesterol acyltransferase deficiency, lipoprotein lipase deficiency, Niemann-Pick disease, primary hyperlipoproteinemia, Smith-Lemli-Opitz syndrome, Werner syndrome
Hematologic No underlying causes
Iatrogenic Parenteral nutrition
Infectious Disease Sepsis
Musculoskeletal / Ortho Smith-Lemli-Opitz syndrome
Neurologic Growth hormone secreting pituitary adenoma
Nutritional / Metabolic Dysglobulinemia, LDL receptor deficiency, omega-3 polyunsaturated fatty acids, selenium deficiency, vitamin E deficiency, Smith-Lemli-Opitz syndrome, apolipoprotein C-II deficiency, apoprotein E deficiency, carnitine palmitoyltransferase 1 deficiency, familial isolated vitamin E deficiency, fructose-1, 6-diphosphatase deficiency, glycogen storage diseases, lecithin cholesterol acyltransferase deficiency, lipoprotein lipase deficiency, Niemann-Pick disease, primary hyperlipoproteinemia
Obstetric/Gynecologic Pregnancy
Oncologic Growth hormone secreting pituitary adenoma
Opthalmologic No underlying causes
Overdose / Toxicity Amprenavir, atazanavir sulfate, atypical antipsychotics, bendrofluazide, beta blockers, bexarotene, chenodeoxycholic acid, chlorthalidone, clofibrate, clozapine, colesevelam hydrochloride, colestyramine, combined oral contraceptive pill, cyclopenthiazide, danazol, desvenlafaxine, doxazosin, etretinate, fosamprenavir, gestrinone, hydrochlorothiazide, interferon alpha, isotretinoin, linagliptin, lopinavir, mitotane, nelfinavir, olanzapine prazosin, progestagens, propofol, protease inhibitors, ritonavir, rosiglitazone, saquinavir, sirolimus, temsirolimus, testosterone, thiazide diuretics, tipranavir, tocilizumab, tofacitinib, torcetrapib
Psychiatric Anorexia nervosa
Pulmonary No underlying causes
Renal / Electrolyte Chronic renal failure, nephrotic syndrome, Alagille syndrome
Rheum / Immune / Allergy Macrophage activation syndrome
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Dental No underlying causes
Miscellaneous Alcohol abuse, benign symmetrical lipomatosis, exercise, high fat diet, obesity, positive family history, sedentary lifestyle, stress, tobacco smoking

Causes in Alphabetical Order

References

  1. ↑ OMIM entry 207750 last updated 02/10/2009
  2. ↑ PMID 227429 (PMID 227429)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  3. ↑ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
  4. ↑ 4.0 4.1 Henderson DC (2001). "Clozapine: diabetes mellitus, weight gain, and lipid abnormalities". J Clin Psychiatry. 62 Suppl 23: 39–44. PMID 11603884.
  5. ↑ Rosenson RS, Baker AL, Chow MJ, Hay RV (1990). "Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis". Gastroenterology. 98 (5 Pt 1): 1351–7. PMID 2323525.
  6. ↑ OMIM entry 118830 updated 03/18/2004
  7. ↑ Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A; et al. (1985). "Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride". Atherosclerosis. 55 (3): 259–66. PMID 3893447.
  8. ↑ O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ (1993). "Hyperlipidemia in patients with primary and secondary hypothyroidism". Mayo Clin Proc. 68 (9): 860–6. PMID 8371604.
  9. ↑ McIntyre N (1988). "Familial LCAT deficiency and fish-eye disease". J Inherit Metab Dis. 11 Suppl 1: 45–56. PMID 3141686.
  10. ↑ Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983). "Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study". Circulation. 67 (5): 968–77. PMID 6219830.
  11. ↑ Osser DN, Najarian DM, Dufresne RL (1999). "Olanzapine increases weight and serum triglyceride levels". J Clin Psychiatry. 60 (11): 767–70. PMID 10584766.
  12. ↑ Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM (1992). "Insulin resistance and cigarette smoking". Lancet. 339 (8802): 1128–30. PMID 1349365.

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Lipoprotein_disorders_causes&oldid=1244178"